GSK completes GBP1 billion IDRx purchase; starts GBP2 billion buyback
(Alliance News) - GSK PLC on Monday said it has completed the acquisition of Boston, Massachusetts-based precision therapeutics firm IDRx Inc, adding to its growing portfolio of treatments for gastrointestinal cancers. Read More